Clinical trial reportNature agingPublished
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease
11 of 43 authors shown in byline order.
Regional connection
Verified Author affiliations on the Europe PMC record name Cooper Medical School of Rowan University, Rowan University. Affiliation source
- County
- Camden County
Publication record
- Type
- Clinical trial report
- Venue
- Nature aging
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Parkinson Disease; Pyrimidines; Proto-Oncogene Proteins c-abl; Protein Kinase Inhibitors; Treatment Outcome; Double-Blind Method; Aged; Middle Aged; Female; Male; Tyrosine Kinase Inhibitors
- PubMed ID
- 41721133
- PubMed Central ID
- PMC13004677
- Open access
- Yes, open
- Added to directory
- Source checked